This script search US Code. View Rule
Skip past Nav Bar
GSA - U.S. General Services Administration Office of Management and Budget
RegInfo.gov Where to find Federal Regulation Information US Flag
Home
Background Image Spacer Unified Agenda and Regulatory Plan Spacer EO 12866 Regulatory Review Spacer Information Collection Review
Current Unified Agenda and Regulatory Plan Historical Unified Agenda and Regulatory Plan Search

View Rule


HHS/FDA RIN: 0910-AC17 Publication ID: Spring 2008 
Title: Institutional Review Boards: Registration Requirements 
Abstract: The final rule would require institutional review boards (IRB) to register with the Department of Health and Human Services. The registration information would include the name of the IRB; the name of the institution operating the IRB; and names, addresses, phone numbers, facsimile (fax) numbers, and electronic mail (e-mail) addresses of the senior officer of the institution and IRB chair or contact; the number of active protocols involving FDA-regulated products reviewed in the previous calendar year; and a description of the types of FDA-regulated products reviewed. The final rule would make it easier for FDA to inspect IRBs and to convey information to IRBs. 
Agency: Department of Health and Human Services(HHS)  Priority: Info./Admin./Other 
RIN Status: Previously published in the Unified Agenda   Agenda Stage of Rulemaking: Final Rule Stage 
Major: No  Unfunded Mandates: No 
CFR Citation: 21 CFR 56.106 
Legal Authority: 21 USC 321; 21 USC 346 to 346a; 21 USC 348; 21 USC 351 to 353; 21 USC 355; 21 USC 360; 21 USC 360c to 360f; 21 USC 360h to 360j; 21 USC 371; 21 USC 379e; 21 USC 381; 42 USC 216; 42 USC 241; 42 USC 262; 42 USC 263b to 263n 
Legal Deadline:  None
Timetable:
Action Date FR Cite
NPRM  07/06/2004  69 FR 40556 
NPRM Comment Period End  10/04/2004   
Final Action  12/00/2008   
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Agency Contact:
Philip L. Chao
Senior Policy Analyst
Department of Health and Human Services
Food and Drug Administration
Room 15-61 (HF-23), Office of Policy and Planning (HF-23), Room 14C-17, 5600 Fishers Lane,
Rockville, MD 20857
Phone:301 827-0587
Fax:301 827-4774
Email: philip.chao@fda.hhs.gov

 
Disclosure   Vertical Spacer Spacer Accessibility   Vertical Spacer Spacer Privacy Policy   Vertical Spacer Spacer Contact Us